Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings

Cancer Treat Res. 2009:147:1-29. doi: 10.1007/978-0-387-09463-2_7.

Authors

Shelly S Lo¹, Kathleen I Pritchard, Patricia Robinson, Kathy S Albain

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, IL, USA, shlo@lumc.edu.

PMID: 21461825
DOI: 10.1007/978-0-387-09463-2_7

No abstract available

MeSH terms

Aromatase Inhibitors*
Breast Neoplasms / prevention & control
Chemotherapy, Adjuvant
Combined Modality Therapy
Humans
Selective Estrogen Receptor Modulators*

Substances

Aromatase Inhibitors
Selective Estrogen Receptor Modulators